Treatment for Myeloproliferative Disorders

How Do I Avoid Neuropathy As a Treatment Side Effect?

Dr. Prithviraj Bose from The University of Texas MD Anderson Cancer Center responds to a member question about peripheral neuropathy as a side effect of treatment for essential thrombocythemia (ET).

Published:

Expert Perspective: Understanding Precision Medicine

From the 2017 ASCO Survivorship Symposium, Dr. Angela Bradbury joined Patient Power to help viewers to explain the role precision medicine in cancer treatment today.

Published:

Pharmacist’s Perspective: Understanding Dosing, Adherence and Drug Interactions

At a recent MPN town meeting, Dr. Jigar Trivedi, a pharmacist at Carolinas HealthCare System's Levine Cancer Institute, shared insight for patients.

Published:

Making Sense of Precision Medicine Test Results

Learn more about personalized medicine, also known as precision medicine, in this web interview with Patient Power Host Andrew Schorr and Dr. Razelle Kurzrock, Director of the Center for Personalized Cancer Therapy at UC San Diego.

Published:

What Does the Future Hold for MPNs? Experts Weigh In

At ASH 2016, MPN experts from across the nation share their perspective on what the future holds for MPNs, in both the short term and long term.

Published:

A Review of Current and Developing Therapies for MPNs

MPN experts from around the nation came together at ASH 2016 to review current and developing therapies for MPNs.

Published:

The Current and Future Status of Pacritinib: An Expert Explains

Over the past year, the investigational oral kinase inhibitor, pacritinib, has been making headlines. To help patients sort through the information and to update us on the status of pacritinib, Dr. John Mascarenhas joined us from Mount Sinai Medical Center in New York City.

Published:

How Does Stem Cell Transplant Work?

MPN expert Dr. Srdan Verstovsek of the University of Texas MD Anderson Cancer Center discusses how stem cell transplant works and the effect on the body.

Published:

Choosing Treatment for Polycythemia Vera (PV)

MPN expert Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center explains how doctors assess patients with polycthemia vera (PV) and determine the best treatment for each individual.

Published:

Showing 9 of 217 programs

Page last updated on October 19, 2015